M K Proteins Limited (MKPL)
₹3.96 +0.00% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, M K's revenue was ₹115 Cr (+0.2% year on year, -21.1% on the previous quarter), and net profit ₹1.4 Cr (-60.7% year on year); the operating margin was 2.2%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹115 | +0.2% | -21.1% |
| Operating profit | ₹2.5 | -54.4% | +0.6% |
| Net profit | ₹1.4 | -60.7% | +21.3% |
| Operating margin | 2.2% | — | — |
MKPL delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 68.9% of the MKPL shares traded on NSE were taken to delivery, against the stock's own 20-session average of 73.45%. That is close to its usual level. Turnover was only ₹2 lakh, so a handful of trades can move this figure.
Delivery in the last 5 sessions: 86.9% · 63.9% · 62.2% · 76.9% · 68.9%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
M K Proteins Limited has issued an intimation regarding the dispatch of letters to shareholders whose email addresses are not registered, providing links and QR codes to access the FY2025-26 Annual Report. The company's 14th Annual General Meeting (AGM) is scheduled for September 30, 2026, via Video Conferencing. The cut-off date for e-voting eligibility is set for September 23, 2026, with the voting window open from September 27 to September 29, 2026.
- 14th Annual General Meeting scheduled for Wednesday, September 30, 2026 at 11:00 AM IST via VC/OAVM
- Cut-off date for e-voting eligibility determined as Wednesday, September 23, 2026
- Remote e-voting window active from September 27, 2026 (09:00 AM) to September 29, 2026 (05:00 PM)
- Communication dispatched under Regulation 36(1)(b) of SEBI LODR Regulations for shareholders without registered emails
M K Proteins Limited has announced its 14th Annual General Meeting (AGM) to be held virtually on Wednesday, September 30, 2026, at 11:00 AM. The company has fixed Wednesday, September 23, 2026, as the cut-off (record) date for determining shareholders eligible to vote electronically. Additionally, the register of members and share transfer books will remain closed from September 24, 2026, to September 30, 2026 (both days inclusive). This is a standard annual corporate compliance filing with no impact on business operations or financials.
- 14th Annual General Meeting scheduled for September 30, 2026, at 11:00 AM via VC/OAVM
- Record/cut-off date for e-voting eligibility fixed as September 23, 2026
- Share transfer books and register of members closed from September 24 to September 30, 2026
M K Proteins Limited has issued the notice for its 14th Annual General Meeting (AGM) to be held on September 30, 2026, via Video Conferencing. Key agenda items include the adoption of FY26 financial statements, the appointment of Ms. Aritika Garg as an Independent Director for a 5-year term, and the re-appointment of director Mr. Raj Kumar. Additionally, the company is seeking shareholder approval for material related-party transactions with M/s Kamla Oleo Pvt Ltd and M/s Kamla Oils and Fats Pvt Ltd. E-voting is scheduled from September 27 to September 29, 2026, with a cut-off date of September 23, 2026.
- 14th AGM scheduled for Wednesday, September 30, 2026, at 11:00 AM via VC/OAVM
- Cut-off date for e-voting set as September 23, 2026; voting window open from September 27 to September 29, 2026
- Proposed appointment of Ms. Aritika Garg as Independent Director for a 5-year term from August 22, 2026
- Shareholder approval sought for material related-party transactions with Kamla Oleo and Kamla Oils & Fats
- Ratification of cost auditor remuneration of Rs. 50,000 per annum for FY2026-27
M K Proteins Limited announced the outcome of its Board meeting held on September 2, 2026. The Board approved the notice and Directors' Report for the 14th Annual General Meeting (AGM), scheduled for September 30, 2026, at 11:00 AM IST via VC/OAVM. Additionally, the register of members and share transfer books will remain closed from September 24, 2026, to September 30, 2026, for the AGM process. The Annual Report for FY26 will be dispatched separately.
- 14th Annual General Meeting scheduled for September 30, 2026, at 11:00 AM via VC/OAVM
- Share transfer books and Register of Members closed from September 24 to September 30, 2026
- Board meeting held on September 2, 2026, from 03:00 PM to 03:30 PM
- Approved the Notice of the 14th AGM and the Directors' Report with annexures for FY26
M K Proteins Limited has appointed Ms. Aritika Garg (DIN: 11895058) as an Additional Director (Non-Executive, Independent) effective August 22, 2026. Her appointment is for a period of 5 years, subject to shareholder approval at the upcoming Annual General Meeting. Ms. Garg is a Chartered Accountant with over 15 years of experience in accounting, finance, taxation, and audit, and is not related to any existing board members.
- Appointment of Ms. Aritika Garg as Additional Director (Non-Executive, Independent) effective August 22, 2026
- Appointed for a tenure of 5 years, subject to approval of shareholders at the AGM
- Appointee has over 15 years of professional experience as a Chartered Accountant
- Board meeting commenced at 03:00 P.M. and concluded at 03:30 P.M. on August 22, 2026
M K Proteins Limited has appointed Ms. Aritika Garg (DIN: 11895058) as an Additional Director in the category of Non-Executive Independent Director, effective August 22, 2026. The appointment is for a period of 5 years, subject to approval from shareholders at the ensuing Annual General Meeting. Ms. Garg is a Chartered Accountant with over 15 years of professional experience in accounting, finance, taxation, and audit. She holds no directorships in other listed companies and is not related to any existing board members.
- Appointment of Ms. Aritika Garg as Non-Executive Independent Director effective August 22, 2026
- Tenure defined for a period of 5 years, subject to shareholder approval at the ensuing AGM
- Appointee brings over 15 years of experience as a qualified Chartered Accountant in finance and audit
- Holds zero directorships in other listed entities and is unrelated to any current directors
M K Proteins Limited (MKPL) reported flat revenue growth for Q1 FY27 at ₹115.16 Cr compared to ₹114.95 Cr in Q1 FY26. However, Net Profit declined sharply by 60.7% YoY to ₹1.38 Cr, down from ₹3.51 Cr, as total expenses consumed a larger portion of revenue. Sequentially, revenue fell 21% from ₹145.94 Cr in Q4 FY26, though profit showed a marginal recovery from ₹1.14 Cr. Additionally, Independent Director Ms. Laxmi Mandal resigned effective August 12, 2026.
- Revenue from operations remained stagnant at ₹115.16 Cr vs ₹114.95 Cr YoY.
- Net Profit fell significantly to ₹1.38 Cr from ₹3.51 Cr in the year-ago period.
- Total expenses rose to 98.4% of revenue in Q1 FY27, up from 95.9% in Q1 FY26.
- Earnings Per Share (EPS) declined to ₹0.04 from ₹0.09 YoY.
- Independent Director Ms. Laxmi Mandal resigned from the board on August 12, 2026.
M K Proteins Limited has informed the exchanges of the resignation of Independent Director Ms. Laxmi Mandal, effective August 12, 2026. The director cited other business obligations as the primary reason and confirmed there are no other material reasons for stepping down. The company currently has a market capitalization of Rs 217 Cr and TTM revenue of Rs 383 Cr. This board change is procedural and has no direct operational or financial impact.
- Resignation of Independent Director Ms. Laxmi Mandal (DIN: 05287716)
- Effective cessation date: August 12, 2026
- Reason cited: Personal business obligations with confirmation of no other material reasons
- Holds directorships and committee memberships in NIL other listed entities
M K Proteins Limited has announced the resignation of Ms. Laxmi Mandal (DIN: 05287716) from the position of Independent Director, effective August 12, 2026. The resignation is attributed to other business obligations, with confirmation that there are no other material reasons. She held directorships and committee memberships in nil other listed entities. The company has a market cap of Rs 217 Cr and reported TTM revenue of Rs 383 Cr.
- Independent Director Laxmi Mandal resigned effective August 12, 2026
- Reason cited is other business obligations, with no other material reasons confirmed
- Holds directorships in NIL other listed entities as per disclosure
- Filing submitted under Regulation 30 of SEBI LODR on August 13, 2026
M K Proteins Limited has informed the exchange that Ms. Laxmi Mandal (DIN: 05287716) has resigned from her position as an Independent Director of the company, effective August 12, 2026. The resignation is attributed to her other business obligations, and she confirmed that there are no other material reasons. She holds directorship in no other listed entities. This is a standard board composition update with no direct impact on daily operations or financials.
- Independent Director Ms. Laxmi Mandal resigned with effect from August 12, 2026
- Reason cited for cessation: other business obligations, with confirmation of no other material reasons
- Resigning director holds NIL directorships or committee memberships in other listed entities
Ms. Laxmi Mandal has resigned from her position as a Non-Executive Independent Director of M K Proteins Limited, effective August 12, 2026. The resignation is attributed to her other business obligations, with a formal confirmation that no other material reasons exist. M K Proteins, a solvent extraction company with a market cap of ₹159 Cr, will need to ensure continued compliance with board composition requirements. This is a routine administrative change and does not impact the company's operational or financial performance.
- Resignation of Ms. Laxmi Mandal effective from August 12, 2026
- Reason cited as 'other business obligations' with no other material reasons confirmed
- The resigning director holds directorships in 0 other listed entities
- Company maintains a TTM revenue of ₹383 Cr and a market cap of ₹159 Cr
M K Proteins Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended June 30, 2026. The Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited, confirmed that no requests for dematerialization or rematerialization were received during the period. The RTA further noted that the entire holding of the company's shares is already in dematerialized form. This is a standard procedural filing required for all listed companies in India.
- Compliance certificate issued for the quarter ended June 30, 2026
- 100% of the company's shares are confirmed to be in dematerialized form
- Zero requests for dematerialization or rematerialization were received during the quarter
- TTM revenue stands at Rs 383 Cr with a promoter holding of 74.82%
M K Proteins Limited (MKPL) has officially notified the stock exchanges regarding the closure of its trading window starting July 1, 2026. This closure is a standard regulatory requirement under SEBI Insider Trading regulations ahead of the announcement of financial results. The window will remain shut for all designated persons, including directors and promoters, until 48 hours after the Q1 FY2026-27 un-audited financial results are declared. The specific date for the board meeting to approve these results is yet to be announced.
- Trading window closure commences on Wednesday, July 1, 2026.
- Closure pertains to the review of Un-Audited Financial Results for the quarter ended June 30, 2026.
- Restriction applies to all Employees, Directors, Promoters, and Key Managerial Personnel.
- The window will reopen 48 hours after the financial results are publicly disclosed.
M K Proteins Limited has submitted its annual disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's Promoter and Promoter Group have declared that no shares were encumbered or pledged, directly or indirectly, during the financial year ending March 31, 2026. This is a routine compliance filing that confirms the status of promoter holdings remains unburdened by debt-related liens.
- Disclosure submitted in compliance with Regulation 31(4) of SEBI (SAST) Regulations, 2011.
- Promoters confirmed zero encumbrances on their shareholding for the full financial year 2025-26.
- The filing covers the company's listings on both the Bombay Stock Exchange (543919) and National Stock Exchange (MKPL).
M K Proteins Limited (MKPL) has approved its audited standalone financial results for the quarter and year ended March 31, 2026. The statutory auditors, Subhash Sajal & Associates, have issued an unmodified opinion, signifying the reliability of the financial statements. To maintain governance continuity, the board re-appointed M/s. K. K. Sinha & Associates as Cost Auditors and M/s. Jayant Bansal & Co. as Internal Auditors for the 2026-27 fiscal year. Additionally, the company confirmed that there are no outstanding defaults on loans or debt securities as of the end of the financial year.
- Approved audited standalone financial results for the quarter and year ended March 31, 2026
- Statutory auditors issued a report with an unmodified opinion on the financial results
- Re-appointed M/s. K. K. Sinha & Associates as Cost Auditors for FY 2026-27
- Re-appointed M/s. Jayant Bansal & Co. as Internal Auditors for FY 2026-27
- Reported zero outstanding defaults on loans and debt securities as of March 31, 2026
Financial Performance
Revenue Growth by Segment
Group revenue is expected to grow by 4-5% in fiscal 2025 and 5% in the medium term. Standalone revenue for MKPL grew 9.01% to INR 267.71 Cr in FY25 from INR 245.57 Cr in FY24. The MKP partnership firm reported TOI of Rs 93.60 Cr in FY24 and expects ~Rs 150 Cr in FY25.
Geographic Revenue Split
Not disclosed in available documents, though operations are primarily concentrated in Gujarat, which is a major producer of groundnuts.
Profitability Margins
Standalone Net Profit Margin declined to 3.14% in FY25 from 4.57% in FY24 due to lower volumes and prices. Group operating margins are expected to remain steady at 6-6.5% over the medium term, aided by backward integration.
EBITDA Margin
Group operating margins are projected at ~6.5% for fiscal 2025. The MKP partnership firm reported an operating profit margin of 3.46% (Rs 3.24 Cr) in FY24.
Capital Expenditure
The group plans modest debt-funded capital expenditure of Rs 10-12 Cr in the medium term. Standalone fixed asset purchases were INR 0.096 Cr in FY25.
Credit Rating & Borrowing
Crisil Ratings: Stable (Group); CARE Ratings: CARE BB-; Stable / CARE A4 (MKP firm). Interest coverage is expected to improve to 13 times in fiscal 2025 from 10 times in fiscal 2024.
Operational Drivers
Raw Materials
Groundnut seeds, rice bran, and sunflower seeds are the primary raw materials used for oil extraction and refining.
Import Sources
Groundnuts are sourced locally from Gujarat (Morbi/Saurashtra). Palm oil imports are influenced by export taxes from Indonesia and Malaysia.
Key Suppliers
Not disclosed in available documents; procurement is done from farmers and wholesalers in the surrounding locality of the manufacturing units.
Capacity Expansion
The MKP unit has an installed capacity of 50 MTPD for groundnut seeds and 20 MTPD for groundnut oil manufacturing. The group periodically expands production capacity to cater to changing customer needs.
Raw Material Costs
Not disclosed as a specific percentage of revenue, but profit margins are highly susceptible to fluctuations in agro-based raw material prices and government MSP changes.
Manufacturing Efficiency
The refinery is completely mechanized to ensure benchmark product quality (fiber-free, ash-free). Group bank limit utilization is moderate at 40-60%.
Logistics & Distribution
Not disclosed as a specific percentage, but locational advantage in Gujarat significantly reduces logistics and storage expenditure.
Strategic Growth
Expected Growth Rate
5%
Growth Strategy
Growth will be achieved through established relationships with key customers, improving geographical diversity, and sustained levels of cleaning, storage, and monitoring in mechanized refineries to meet customer specifications.
Products & Services
Groundnut refined oil, rice bran oil, sunflower oil, groundnut oil cake, and groundnut seeds.
Market Expansion
The group is focused on improving geographical diversity and increasing production capacity to cater to varied customer needs.
Market Share & Ranking
Not disclosed in available documents; the industry is noted as highly fragmented with numerous players.
External Factors
Industry Trends
The edible oil industry is highly fragmented and competitive, with a shift toward mechanized refining and benchmark product quality to meet customer requirements.
Competitive Landscape
Intense competition from numerous fragmented players and aggressive pricing by competing brands create potential for disruption.
Competitive Moat
Locational advantage in Gujarat (the largest groundnut producer) provides a sustainable cost moat by reducing logistics and procurement costs.
Macro Economic Sensitivity
Highly sensitive to monsoon patterns affecting oilseed procurement and changes in the Minimum Support Price (MSP) offered by the government.
Consumer Behavior
Customers exhibit high price sensitivity, switching to cheaper international imports when domestic realizations are high.
Geopolitical Risks
Profitability is sensitive to changes in export taxes levied by major exporting countries like Indonesia and Malaysia on palm oil.
Regulatory & Governance
Industry Regulations
Operations are affected by import-export regulations, minimum support price (MSP) on oilseeds, and mechanized refinery standards.
Legal Contingencies
The company faces contingent liabilities relating to taxation, litigations, and claims arising in the normal course of business; specific INR values are not disclosed.
Risk Analysis
Key Uncertainties
Volatility in raw material prices and realization corrections (which caused a 22% revenue decline in FY24) are the primary business uncertainties.
Geographic Concentration Risk
High geographic concentration with manufacturing facilities and raw material procurement centered in Gujarat.
Third Party Dependencies
High dependency on farmers and wholesalers for the procurement of oilseeds at the right price and quantity.
Technology Obsolescence Risk
Low risk as the company uses mechanized refineries and benchmark technology to ensure product quality.
Credit & Counterparty Risk
Liquidity is stretched for the MKP firm with 95% working capital utilization, though the group maintains adequate free cash of Rs 50 Cr.